Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adjuvant tamoxifen and chemotherapy in stage II breast cancer: interim findings from NSABP protocol B-09.

× No keyword cloud information.

4 in total

1. 1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings.

Authors: B Fisher; P Carbone; S G Economou; R Frelick; A Glass; H Lerner; C Redmond; M Zelen; P Band; D L Katrych; N Wolmark; E R Fisher
Journal: N Engl J Med Date: 1975-01-16 Impact factor: 91.245

2. Evaluation of survival data and two new rank order statistics arising in its consideration.

Authors: N Mantel
Journal: Cancer Chemother Rep Date: 1966-03

3. Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer.

Authors: B Fisher; C Redmond; A Brown; D L Wickerham; N Wolmark; J Allegra; G Escher; M Lippman; E Savlov; J Wittliff
Journal: J Clin Oncol Date: 1983-04 Impact factor: 44.544

4. Treatment of primary breast cancer with chemotherapy and tamoxifen.

Authors: B Fisher; C Redmond; A Brown; N Wolmark; J Wittliff; E R Fisher; D Plotkin; D Bowman; S Sachs; J Wolter; R Frelick; R Desser; N LiCalzi; P Geggie; T Campbell; E G Elias; D Prager; P Koontz; H Volk; N Dimitrov; B Gardner; H Lerner; H Shibata
Journal: N Engl J Med Date: 1981-07-02 Impact factor: 91.245

4 in total

1. The Stockholm trial on adjuvant tamoxifen in early breast cancer. Correlation between estrogen receptor level and treatment effect.

Authors: L E Rutqvist; B Cedermark; U Glas; H Johansson; B Nordenskjöld; L Skoog; A Somell; T Theve; S Friberg; J Askergren
Journal: Breast Cancer Res Treat Date: 1987-12 Impact factor: 4.872

2. In vitro sensitivity testing of human breast cancer cells to hormones and chemotherapeutic agents.

Authors: J T Emerman; A W Tolcher; P M Rebbeck
Journal: Cancer Chemother Pharmacol Date: 1990 Impact factor: 3.333

3. Postmenopausal patients with node-positive resectable breast cancer. Tamoxifen vs FEC 50 (6 cycles) vs FEC 50 (6 cycles) plus tamoxifen vs control--preliminary results of a 4-arm randomised trial. The French Adjuvant Study Group.

Authors: J P Gérard; M Héry; D Gedouin; A Monnier; M J Goudier; J P Jacquin; F Plat; E Cabarrot; D Serin; M Namer
Journal: Drugs Date: 1993 Impact factor: 9.546

Review 4. The predictive value of steroid hormone receptor analysis in breast, endometrial and ovarian cancer.

Authors: R Vihko; A Alanko; V Isomaa; A Kauppila
Journal: Med Oncol Tumor Pharmacother Date: 1986

4 in total